# AN2 Therapeutics, Inc.: Form 8-K, filed Aug 19, 2024

- Company: [AN2 Therapeutics, Inc.](/companies/antx.md) (CIK 1880438)
- Form: 8-K
- Filed: 2024-08-19
- Accepted by EDGAR: Aug 19, 2024, 06:04 ET
- Period: 2024-08-15
- Accession: 0001193125-24-202430
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1880438/000119312524202430/d879523d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1880438/000119312524202430/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.03: Change to security holders’ rights
- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1880438/000119312524202430/d879523d8k.htm

Filed Aug 19, 2024.
Source: SEC EDGAR, the filing index for accession 0001193125-24-202430. Last ingested by Listed: Nov 15, 2026, 04:15 ET. No prices; not investment advice.
